Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhengyang Feng

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Bioengineering and Biotechnology|September 2, 2024
Establishment of the microscope incubation system and its application in evaluating tumor treatment effects through real-time live cellular imagingHaiyang Yan, Tong Wu, Xinlu Li, et al.
BMC Cancer|October 16, 2020
Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancerQiliang Peng, Yi Shen, Peifeng Zhao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2025
Comprehensive multi-omics analysis of bile acid metabolism in hepatocellular carcinoma: implications for prognosis, immune microenvironment, and therapeutic resistanceJiayan Ma, Ming Cheng, Limin Jin, et al.
BMC Medical Genomics|May 19, 2025
MicroRNA-486: a dual-function biomarker for diagnosis and tumor immune microenvironment characterization in non-small cell lung cancerJun Yu, Yi Shen, Yao Xu, et al.
Cancer Medicine|August 27, 2019
Identification of microRNA-181 as a promising biomarker for predicting the poor survival in colorectal cancerQiliang Peng, Wenyan Yao, Chenxiao Yu, et al.
BMC Cancer|December 18, 2024
Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patientsQiliang Peng, Changli Zhan, Yi Shen, et al.
BMC Medical Genomics|March 13, 2025
Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapyQiliang Peng, Yi Shen, Yingying Xu, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort studyJialong Tao, Yingtian Zhang, Yanjie Wang, et al.
BMC Genomics|June 27, 2023
Construction and validation of a prognostic model based on autophagy-related genes for hepatocellular carcinoma in the Asian populationYanjie Wang, Sijia Huang, Yingtian Zhang, et al.
Journal of Cancer|October 22, 2019
Identification of biomarker microRNA-mRNA regulatory pairs for predicting the docetaxel resistance in prostate cancerJian Tu, Qiliang Peng, Yi Shen, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|September 2, 2024
Establishment of the microscope incubation system and its application in evaluating tumor treatment effects through real-time live cellular imagingHaiyang Yan, Tong Wu, Xinlu Li, et al.
BMC Cancer|October 16, 2020
Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancerQiliang Peng, Yi Shen, Peifeng Zhao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2025
Comprehensive multi-omics analysis of bile acid metabolism in hepatocellular carcinoma: implications for prognosis, immune microenvironment, and therapeutic resistanceJiayan Ma, Ming Cheng, Limin Jin, et al.
BMC Medical Genomics|May 19, 2025
MicroRNA-486: a dual-function biomarker for diagnosis and tumor immune microenvironment characterization in non-small cell lung cancerJun Yu, Yi Shen, Yao Xu, et al.
Cancer Medicine|August 27, 2019
Identification of microRNA-181 as a promising biomarker for predicting the poor survival in colorectal cancerQiliang Peng, Wenyan Yao, Chenxiao Yu, et al.
BMC Cancer|December 18, 2024
Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patientsQiliang Peng, Changli Zhan, Yi Shen, et al.
BMC Medical Genomics|March 13, 2025
Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapyQiliang Peng, Yi Shen, Yingying Xu, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort studyJialong Tao, Yingtian Zhang, Yanjie Wang, et al.
BMC Genomics|June 27, 2023
Construction and validation of a prognostic model based on autophagy-related genes for hepatocellular carcinoma in the Asian populationYanjie Wang, Sijia Huang, Yingtian Zhang, et al.
Journal of Cancer|October 22, 2019
Identification of biomarker microRNA-mRNA regulatory pairs for predicting the docetaxel resistance in prostate cancerJian Tu, Qiliang Peng, Yi Shen, et al.
Pageof 3